Results 81 to 90 of about 161,781 (188)

High cyclin‐dependent kinase inhibitors in Bcl‐2 and Bcl‐x_L‐expressing CD34⁺‐proliferating haematopoietic progenitors [PDF]

, 2000
Maria Marone, Luca Pierelli, Simona Mozzetti, Valeria Masciullo, Giuseppina Bonanno, Roberta Morosetti, Sergio Rutella, Alessandra Battaglia, Carlo Rumi, Salvatore Mancuso, Giuseppe Leone, Antonio Giordano, Giovanni Scambia   +12 more
openalex   +1 more source

Platelet rich plasma releasate promotes proliferation of skeletal muscle cells in association with upregulation of PCNA, cyclins and cyclin dependent kinases

Platelets, 2017
Platelet rich plasma (PRP) contains various cytokines and growth factors which may be beneficial to the healing process of injured muscle. The purpose of this study is to investigate the effect and molecular mechanism of PRP releasate on proliferation of
Wen-Chung Tsai, Tung-Yang Yu, Li-Ping Lin, Miao-Sui Lin, Yi-Cheng Wu, Chih-Hao Liao, Jong-Hwei S. Pang   +6 more
doaj   +1 more source

Molecular docking analysis of selected pyrimidine derivatives with human cyclin-dependent kinase 2. [PDF]

Bioinformation, 2021
Bharathi R, Santhi N.
europepmc   +1 more source

Supplementary Figure 2 from Phase I, Dose-Escalation Trial of the Oral Cyclin-Dependent Kinase 4/6 Inhibitor PD 0332991, Administered Using a 21-Day Schedule in Patients with Advanced Cancer [PDF]

, 2023
Keith T. Flaherty, Patricia LoRusso, Angela DeMichele, Vandana G. Abramson, Rachel Courtney, Sophia Randolph, M. Naveed Shaik, Keith D. Wilner, Peter J. O’Dwyer, Gary K. Schwartz   +9 more
openalex   +1 more source

High phosphorylated cyclin-dependent kinase 2 expression indicates poor prognosis of luminal androgen receptor triple-negative breast cancer. [PDF]

Acta Biochim Biophys Sin (Shanghai), 2022
Jin Z, Zhang Q, Wang C, Wang S, Lin L, Zou R, Sun G, Zeng K, Zhou B, Tong Y, Chen B, Zhao Y.   +11 more
europepmc   +1 more source

Discovery of INCB123667, a potent and selective cyclin-dependent kinase 2 (CDK2) inhibitor for the treatment of cyclin E dysregulated cancers [PDF]

, 2022
Susan Wee, M. Ye, Y. Lo, M. Hansbury, N. Shin, M. Weber, V. Roman, L. Huo, H. Skaggs, K. Drake, K. Kapilashrami, K. Stump, J. Yang, S. Chand, C. Timmers, Joshua Hummel, Yu Wei Ye, G. Zhang, Y.O. Yang, M. Covington, L. Wu, H. Koblish, S. Kim   +22 more
openalex   +1 more source

Collaborative Approach between Explainable Artificial Intelligence and Simplified Chemical Interactions to Explore Active Ligands for Cyclin-Dependent Kinase 2. [PDF]

ACS Omega, 2022
Shimazaki T, Tachikawa M.
europepmc   +1 more source

Discovery of new 5-substituted-indole-2-carboxamides as dual epidermal growth factor receptor (EGFR)/cyclin dependent kinase-2 (CDK2) inhibitors with potent antiproliferative action. [PDF]

RSC Med Chem, 2023
Mohamed FAM, Alakilli SYM, El Azab EF, Baawad FAM, Shaaban EIA, Alrub HA, Hendawy O, Gomaa HAM, Bakr AG, Abdelrahman MH, Trembleau L, Mohammed AF, Youssif BGM.   +12 more
europepmc   +1 more source

Supplementary Figures S2 from Cyclin-Dependent Kinase 2 Functions in Normal DNA Repair and Is a Therapeutic Target in BRCA1-Deficient Cancers

, 2023
Andrew J. Deans, Kum Kum Khanna, Carolyn J. McNees, Ciro Mercurio, Jörg Heierhorst, Grant A. McArthur   +5 more
openalex   +1 more source

Greatwall-Endos-PP2A/B55Twins network regulates translation and stability of maternal transcripts in the Drosophila oocyte-to-embryo transition

Open Biology
The transition from oocyte to embryo requires translation of maternally provided transcripts that in Drosophila is activated by Pan Gu kinase to release a rapid succession of 13 mitotic cycles.
Hélène Rangone, Laura Bond, Timothy T. Weil, David M. Glover   +3 more
doaj   +1 more source